A commentary published in Nature this week argues that the National Institutes of Health is not meeting its mandate to fund "the best science, by the best scientists."

Indeed, based on an analysis of 1,380 papers published since 2001 that have received 1,000 citations or more — a "proxy" measurement for the influence of the work — the authors found that "three out of five authors of these influential papers do not currently have NIH funding as principal investigators."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.